Onyx Biotec Ltd

Onyx Biotec Open Offer

VC Corporate Advisors filed a corrigendum to Onyx Biotec's open offer letter of offer. The offer seeks up to 47,14,372 shares, or 26% of paid-up capital.

Onyx Biotec Other Announcement

Onyx Biotec Limited has submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.

Onyx Biotec Open Offer

Onyx Biotec's Committee of Independent Directors met to review the open offer by the identified acquirers to purchase 26% of the company's equity share capital.

Onyx Biotec Open Offer: ₹17.21 Cr

Bhardwaj acquirers launch a ₹172.07 Crore open offer for 26% of Onyx Biotec at ₹36.5 per share. Tendering runs October 13–27, 2026.

Value

₹17.21 Cr

Onyx Biotec Annual General Meeting

Onyx Biotec Limited held its 21st Annual General Meeting on September 28, 2026. The meeting covered standard agenda items including financial statement adoption and director appointments.

Onyx Biotec Annual General Meeting

Onyx Biotec Limited will hold its 21st Annual General Meeting on September 28, 2026, via video conferencing to transact the company's business.

Onyx Biotec Management Change

Onyx Biotec Limited has announced a change in the designation of Mr. Naresh Kumar from Whole-Time Director to Executive Director, effective September 3, 2026.

Onyx Biotec Board Meeting Outcome

Onyx Biotec Ltd. announced its board meeting outcomes, including the 21st AGM convening, cost auditor appointment, and a director's designation change to Managing Director.